The effects of Donepezil on traumatic brain injury acute rehabilitation outcomes.
To evaluate the effects of administering Donepezil during inpatient rehabilitation for individuals with TBI. Retrospective, age and injury severity matched, mixed between-within subjects analysis. Thirty-six patients with moderate-to-severe TBI admitted to acute rehabilitation within 90 days of injury. Main outcome measures included FIM cognitive total scores and rehabilitation lengths of stay. Initiation of Donepezil administration beginning at 5 mg daily. Dose titration and continuation based on perceived clinical response. No differences in cognitive improvement were observed between the Donepezil treatment group and the matched control group. Sub-set analyses suggested that administration of Donepezil early in the rehabilitation stay was significantly related to higher rates of cognitive improvement. Preliminary evidence suggests that Donepezil administration early in the rehabilitation stay may have advantageous treatment effects. A prospective, randomized, placebo-controlled clinical trial with standard timing, dosage and treatment duration is recommended to further evaluate treatment efficacy.